Incorporated into single-dose IT rat (CNS) and 13-week IT monkey study (CNS, CV, respiratory); hERG in vitro
“Safety pharmacology assessments following IT administration of tofersen were incorporated into a single dose study in male and female SD rats (CNS) and a 13-week repeat (Q2W) dose toxicity study in cynomolgus monkeys (CNS, CV, and respiratory).”